19 December 2024

Howe Street Reporter Title

Tag: depression

  • Top 5 stock gainers and losers: ELMT.C, HSLV.C, PLRB.V

    Top 5 stock gainers and losers: ELMT.C, HSLV.C, PLRB.V

    In this summary report, we will take a quick look at the top 5 gainers and losers up or down double digits on the Canadian stock markets. Here is a summary of the intraday action of assets: Top 5 Gainers Element Nutritional Sciences (ELMT.C) Market Cap ~ $6.8 million Element Nutritional Sciences employs plant-based technology…

  • Filament Health (FH.NEO) brings an all natural option to fight depression and anxiety

    Filament Health (FH.NEO) brings an all natural option to fight depression and anxiety

    You’d be hard pressed to find someone who hasn’t been touched by depression or anxiety. Biochemically, they’re considered co-morbid, which means they often happen at the same time and feed off of one another. Depression and anxiety often overlap in terms of neurotransmitters and therefore, they’re often lumped together and treated the same way. And…

  • A Closer Look: ThinkMyco pushes the button on magic mushroom market

    A Closer Look: ThinkMyco pushes the button on magic mushroom market

    Psilocybin and other psychedelics are forcing their way out of prohibition as potentially viable treatments for not only depression and anxiety but also Alzheimer’s and other neurodegenerative diseases plaguing millions in North America alone. In the end, psilocybin solutions address a $300 billion dollar psychotherapy and wellness global market. Shroom Stocks’ own Ethan Reyes spoke…

  • A ‘growing’ concern: With the cannabis bubble bursting, are mushrooms the next gold rush?

    A ‘growing’ concern: With the cannabis bubble bursting, are mushrooms the next gold rush?

    “Cannabis is dead; long live cannabis.” Mushrooms, mark my words.. –Ancient potstocks proverb Seriously though, folks, the cannabis sector is in trouble. Take a look at the Horizons Marijuana Life Sciences ETF, a basket of some of the largest cannabis stocks on the market. Here is equity.guru founder, Chris Parry’s take on how the growing pains of…